Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Hemostemix
493
Hemostemix
Technology
Biotechnology
Hemostemix is a public clinical-stage company that develops innovative blood-derived cell therapies for medical conditions not yet adequately addressed.
Suggest edits
Founded
2006
Raised
$4.4M
Follow us
Companies in the same industry
Dedalus Group
Synthorx
Geno
Penn Medicine
European Investment Fund (EIF)
Altacor
Avesthagen
CellPly
Diagnostic Healthcare
Advaxis
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$4,400,000
Debt financing - 2017
Wood Capital
Team Size
2
Employees
I work here
Location
Canada
Headquarters
Explore Canada
$4,400,000
Debt financing
PE HUB
Hemostemix nets $4.4 mln in debt funding, aims for $8 mln more
Stock markets
Legal
Privacy
